Yao XQ, Liu FK, Li JS, Qi XP, Wu B, Yin HL, Ma HH, Shi QL, Zhou XJ. Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma. World J Gastroenterol 2004; 10(9): 1262-1267 [PMID: 15112339 DOI: 10.3748/wjg.v10.i9.1262]
Corresponding Author of This Article
Xue-Quan Yao, Department of General Surgery, Jinling Hospital, 305 Zhongshangdong Road, Nanjing, 210002, Jingsu Province, China. yaoxuequan@yahoo.com
Article-Type of This Article
Gastric Cancer
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. May 1, 2004; 10(9): 1262-1267 Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1262
Table 1 No Correlation between EPR-1 protein expression and clinicopathological parameters
Clinico-pathological parameters
Cases
EPR-1 positive cases n (%)
P value
Age (yr)
<60
37
21 (56.8)
60
83
56 (67.5)
0.258
Sex
Male
72
43 (59.7)
Female
48
34 (70.8)
0.214
Tumor location
Upper 1/3
39
22 (56.4)
Middle 1/3
32
20 (62.5)
Lower 1/3
19
11 (57.9)
More than 2 locaitons
30
24 (80.0)
0.199
Differentation
Well
60
46 (76.7)
Poorly
60
31 (51.7)
0.004
Subtypes
Papillary
30
24 (80.0)
Tubular
30
22 (73.3)
Mucinous
30
13 (43.3)
Signet-ring cell
30
18 (60.0)
0.017
Invasion mucosa
No
66
40 (60.6)
Yes
54
37 (68.5)
0.369
Lymph node metastasis
No
70
43 (61.4)
Yes
50
34 (68.0)
0.459
Table 2 Different expression of EPR-1 between histological subtypes
Subtypes
Primary carcinoma
P value
Normal gastric mucosa
P value
Invasion node
P value
Lymph node metastasis
P value
Smooth muscle cell
P value
Papillary
24/30 (80.0)
14/30 (46.7)
14/17 (82.4)
11/13 (84.6)
17/30 (56.7)
Tubular
22/30 (73.3)
15/30 (50.0)
12/16 (75.0)
11/15 (73.3)
15/30 (50.0)
Mucinous
13/30 (43.3)
12/30 (40.0)
10/24 (41.7)
3/10 (30.0)
14/30 (46.7)
Signet-ring cell
18/30 (60.0)
0.017
15/30 (50.0)
0.849
11/28 (39.3)
0.007
9/12 (75.0)
0.033
18/30 (60.0)
0.72
Table 3 Different expression of EPR-1 in the highly-differentiated adenocarcinomas
Differentation
Primary gastric adenocar cinoma
Normal gastric mucosa cells
Invasion node adenocarcinoma
Lymph node metastasis
Smooth muscle cell
P value
Well
46/60 (76.7)
29/60 (48.3)
26/33 (78.8)
22/28 (78.6)
32/60 (53.3)
0.002
Poorly
31/60 (51.7)
27/60 (45.0)
21/52 (40.4)
12/15 (54.5)
32/60 (53.3)
0.594
Table 4 Significant expression difference of the AI and PI between EPR-1 positive and negative groups in primary adenocarcinomas
EPR-1
n
AI (%), mean ± SD
P value
PI (%), mean ± SD
P value
+
77
1.25±0.86
7.00 ± 3.28
-
43
1.00±0.80
0.024
8.53 ± 2.70
0.01
Table 5 Significant expression difference of the AI and PI be-tween EPR-1 positive and negative groups in lymph node metastasis
EPR-1
n
AI (%)
P value
PI (%)
P value
+
34
0.99 ± 0.58
7.65 ± 2.60
-
16
0.67 ± 0.24
0.01
9.44 ± 3.05
0.037
Citation: Yao XQ, Liu FK, Li JS, Qi XP, Wu B, Yin HL, Ma HH, Shi QL, Zhou XJ. Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma. World J Gastroenterol 2004; 10(9): 1262-1267